Governance Ipsen

IPN

FR0010259150

Prodotti farmaceutici

Mercato chiuso - Euronext Paris Altri mercati azionari 17:55:00 13/01/2026			Variaz. 5gg	Var. 1 gen.
127,50 ^EUR	-1,39%		+8,97%	+7,14%

13/01	Ipsen: la FDA statunitense concede la designazione di terapia innovativa a IPN60340 nella leucemia mieloide acuta di prima linea non idonea	RE
08/01	UBS non consiglia più l'acquisto di Ipsen, considerata ormai correttamente valutata

Comitato esecutivo: Ipsen

Manager

Posizioni ricoperteDa

David Loew

58 anni

Chief Executive Officer

01/07/2020

Aymeric Le Chatelier

56 anni

Director of Finance/CFO

03/11/2014

Khalid Deojee

Investor Relations Contact

01/01/2025

Christelle Huguet

59 anni

Chief Tech/Sci/R&D Officer

22/09/2023

Sandra Silvestri

52 anni

Chief Tech/Sci/R&D Officer

05/05/2023

Aidan Murphy

59 anni

Chief Tech/Sci/R&D Officer

01/01/2018

Regis Mulot

59 anni

Human Resources Officer

12/03/2018

Composizione del Consiglio di amministrazione: Ipsen

Amministratore

ComitatiDa

Marc M. P. de Garidel

67 anni

Chairman

22/11/2010

Carol Xueref

69 anni

Compensation Committee	01/06/2012
Governance Committee	01/06/2012
Nominating Committee Chair	13/04/2015
Compensation Committee Chair	13/04/2015

Philippe Bonhomme

56 anni

Audit Committee	01/06/2020
Governance Committee	01/06/2020
Nominating Committee	01/06/2020

Margaret Liu

68 anni

Governance Committee Chair	07/06/2017
Governance Committee	03/01/2023
Nominating Committee	03/01/2023

Piet Wigerinck

60 anni

Compensation Committee

01/05/2018

Laetitia Ducroquet

46 anni

Compensation Committee

Naomi Binoche

Governance Committee

Antoine Flochel

61 anni

Compensation Committee Chair

16/11/2010

Karen Witts

63 anni

Compensation Committee

21/01/2022

Michèle Ollier

67 anni

Director/Board Member	27/05/2015
Independent Dir/Board Member	27/05/2015

Pascal Touchon

63 anni

Director/Board Member

01/10/2023

David Loew

58 anni

Director/Board Member

01/07/2020

Ultime nomine: Ipsen

01/12	Ipsen annuncia la scomparsa del membro del Consiglio Henri Beaufour il 28 novembre 2025	CI
23/07/25	Ipsen S.A. annuncia nuove nomine nel Comitato Esecutivo	CI
23/07/25	Ipsen: tre nomine nel comitato esecutivo
06/05/25	Ipsen nomina Laura Révéillon EVP, Strategy & Transformation con effetto dal 14 maggio 2025	CI
12/03/25	Ipsen: nomina di un responsabile globale delle neurotossine
04/03/25	Oncodesign Precision Medicine nomina Christophe Thurieau come membro del Consiglio di Amministrazione	CI
09/12/24	Nuvalent, Inc. nomina Grant Bogle nel Consiglio di Amministrazione	CI

Altre notizie

Ex dirigenti e amministratori: Ipsen

Insider

Posizioni ricoperte

DaA

Henri Beaufour

Director/Board Member

19/09/2005

28/11/2025

Craig Marks

Investor Relations Contact

01/09/2025

François-Maurice Garnier

General Counsel	05/01/2015	01/09/2025
Corporate Secretary	-	01/09/2025

Catherine Abi-Habib

Corporate Officer/Principal

01/03/2022

14/05/2025

Gwenan White

Public Communications Contact

01/03/2021

19/08/2024

Howard Mayer

Chief Tech/Sci/R&D Officer

01/12/2019

22/09/2023

Igor Matushansky

Corporate Officer/Principal

01/07/2022

01/06/2023

Steven Hildemann

Chief Tech/Sci/R&D Officer

01/03/2020

05/05/2023

Paul Sekhri

Director/Board Member	01/05/2018	01/01/2023
Independent Dir/Board Member	01/05/2018	01/01/2023

Chi Nguyen

Private Equity Investor

01/03/2022

02/11/2022

Dominique Bery

Corporate Officer/Principal

01/04/2017

01/03/2022

Carol Stuckley

Director/Board Member	07/06/2017	01/08/2021
Independent Dir/Board Member	07/06/2017	01/08/2021

Milenko Cicmil

Corporate Officer/Principal

01/05/2019

31/07/2021

Christian Marcoux

Public Communications Contact

01/12/2018

01/09/2020

Harout Semerjian

Corporate Officer/Principal

01/03/2018

01/04/2020

Christy Oi

Director of Finance/CFO

01/11/2016

01/04/2020

Ivana Magovcevic-Liebisch

Corporate Officer/Principal

12/03/2018

01/04/2020

David Meek

Director/Board Member	06/07/2017	01/01/2020
Chief Executive Officer	18/07/2016	01/01/2020

Alexandre LeBeaut

Chief Tech/Sci/R&D Officer

01/01/2013

01/12/2019

Sotirios G. Stergiopoulos

Chief Tech/Sci/R&D Officer

01/01/2017

01/06/2019

Didier Véron

Public Communications Contact

01/01/2013

01/12/2018

Jean-Marc Parant

Director/Board Member

27/11/2018

Christophe Jean

Chief Operating Officer	01/09/2002	01/11/2013
Corporate Officer/Principal	01/11/2013	01/07/2018

Christophe Vérot

Director/Board Member

27/05/2011

30/05/2018

Hélène Auriol-Potier

Director/Board Member	04/06/2014	30/05/2018
Independent Dir/Board Member	04/06/2014	30/05/2018

Hervé Couffin

Director/Board Member	30/08/2005	30/05/2018
Independent Dir/Board Member	30/08/2005	30/05/2018

Pierre Martinet

Director/Board Member	19/09/2005	30/05/2018
Independent Dir/Board Member	19/09/2005	30/05/2018

Ian Weatherhead

Public Communications Contact

14/09/2017

Sonia Benhamida

Director/Board Member	01/07/2010	01/09/2017
Private Equity Investor	01/07/2016	01/09/2017

Siham Imani

Corporate Officer/Principal

01/01/2011

01/04/2017

Jean Fabre

Corporate Officer/Principal

01/01/2008

10/03/2017

Claude Bertrand

Chief Tech/Sci/R&D Officer

01/11/2009

02/01/2017

Christopher Cozic

Human Resources Officer

01/01/2014

01/01/2017

Christophe Thurieau

Corporate Officer/Principal

01/01/1996

01/01/2017

Philippe Robert-Gorsse

Corporate Officer/Principal

01/01/2005

31/12/2016

Eugenia Litz

Investor Relations Contact

02/06/2016

Stéphane Durant des Aulnois

Investor Relations Contact

02/06/2016

Christel Bories

Corporate Officer/Principal

01/03/2013

01/03/2016

Martha Heitzmann-Crawford

Director/Board Member	31/05/2013	01/01/2016
Independent Dir/Board Member	31/05/2013	01/01/2016

Stéphane Bessette

Human Resources Officer

01/10/2015

Dominique Laymand

Compliance Officer

16/03/2015

Nathalie Joannes

General Counsel

12/10/2011

05/01/2015

Susheel Surpal

Director of Finance/CFO

01/12/2011

31/10/2014

Gérard Hauser

Director/Board Member

22/10/2009

04/07/2014

Jonathan Henry Barnsley

Chief Tech/Sci/R&D Officer

01/04/2014

Dominique Brard

Human Resources Officer

06/01/2014

Heather White

Comptroller/Controller/Auditor

01/01/2014

Pierre Kemula

Public Communications Contact	22/10/2009	01/01/2014
Treasurer	01/01/2008	01/01/2014

Klaus-Peter Schwabe

Director/Board Member

22/10/2009

31/05/2013

Richard B. Love

Corporate Officer/Principal

01/05/2012

David S. Schilansky

Director of Finance/CFO	01/01/2006	01/12/2011
Public Communications Contact	01/01/2006	01/12/2011

Claire Giraut

Chief Administrative Officer	22/10/2009	01/10/2011
Director of Finance/CFO	01/01/2003	01/10/2011

Thomas Gidoin

Comptroller/Controller/Auditor

01/01/2008

01/01/2011

Jean-Luc Bélingard

Chief Executive Officer	01/01/2002	22/11/2010
Chairman	01/01/2002	22/11/2010

Andrew Grethlein

Corporate Officer/Principal

01/10/2008

01/01/2010

Gérard Picot

General Counsel

22/05/2008

Frédéric Babin

Human Resources Officer

17/03/2008

Pierre Boisselier

Treasurer

01/01/2007

01/01/2008

Sean P. McKercher

Corporate Officer/Principal

16/04/2007

Stéphane Thiroloix

Corporate Officer/Principal

01/04/2007

Alistair Stokes

Corporate Officer/Principal

01/01/2007

Benoit Hennion

Corporate Officer/Principal

13/03/2017

René Merkt

Director/Board Member

22/10/2009

Yves Rambaud

Director/Board Member

22/10/2009

Ernest Loumaye

Corporate Officer/Principal

01/01/2003

Pierre Boulud

Corporate Officer/Principal

01/01/2002

François Thomas

Chief Tech/Sci/R&D Officer

01/01/1990

01/01/1994

Jacques Moreau

Chief Tech/Sci/R&D Officer

01/01/1994

Pascale Richetta

Sales & Marketing

01/01/1990

01/01/1994

Sandrine Téran

Corporate Officer/Principal

01/01/1991

Olivier Jochem

Corporate Secretary

Etienne de Blois

Human Resources Officer	12/05/2011	07/01/2014
Corporate Officer/Principal	07/01/2014	-

Georges le Donge

Corporate Officer/Principal

Ioana Piscociu

Public Communications Contact

Viviane Montarnal

Corporate Officer/Principal

Grégoire Pierre Prevost

Corporate Officer/Principal

Peter Koetsier

Corporate Officer/Principal

Alain Béguin

Director/Board Member

22/10/2009

Septien-Velez Septién

Corporate Officer/Principal

Joël Richard

Corporate Officer/Principal

Eric Drapé

Corporate Officer/Principal

02/05/2007

Alain Haut

Human Resources Officer

Sébastien Bessy

Corporate Officer/Principal	-	-
Sales & Marketing	-	-

Distribuzione dell'età dei dirigenti

Parità di genere

Uomo	16
Donna	6

Di cui Comitato esecutivo

Uomo	7
Donna	0

Di cui Direttori

Uomo	8
Donna	4

Revisioni

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Ipsen è specializzata nella ricerca, nello sviluppo, nella produzione e nella commercializzazione di specialità medicinali. Le vendite nette per area terapeutica si suddividono come segue: - oncologia (73,7%); - neuroscienze (20,6%); - malattie rare (5,7%). Alla fine del 2024, il Gruppo aveva 4 centri di ricerca e sviluppo situati in Francia, Regno Unito, Stati Uniti e Cina, e 4 siti di produzione in tutto il mondo. Le vendite nette sono distribuite geograficamente come segue: Europa (39,3%), Nord America (34,3%) e altri (26,4%).

Dipendenti

5.358

Settore

Prodotti farmaceutici

Calendario

12/02 - Q4 2025 Pubblicazione dei risultati

Altre informazioni sulla società